PBAC to consider three lymphoma drugs
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
- Treatments and side-effects
Associate Professor Michael Dickinson says CAR T-cell therapy is a 'revolutionary step forward'.
We stand with Indigenous Australians to close the gap in health. We know we need to do better for our First Nations people living with blood cancer.
Blood cancer survivor and midwife, Catherine Wheeler shares her experience being eligible for the Phase 1a COVID-19 vaccine rollout.
When diagnosed with a blood cancer as a young adult, Vicky Pellowe struggled to find the relevant information she needed to manage her diagnosis and live well as a survivor.
Patrick won't let his lymphomas stop him from achieving his two milestones - to walk 10 kilometres, and to swim 200 metres butterfly!
“COVID’s been good to me and quite a few other patients”, says Andrew Warden, who volunteered to be a “guinea pig” on a program initiated by Professor Judith Trotman.
A resubmission will be considered from Kyowa Kirin for relapsed or refractory (R/R) cutaneous T-cell lymphoma.
It’s been 10 years since John Taylor’s last follow-up consultation with his haematologist.
Pauline Vedelago tells the story of her husband of 31 years, Trevor.